New issue of Blood out now featuring: Acalabrutinib to assail CLL in the frail, Matchmaking gene therapy with mimetic antibodies, Beyond Arg39: new insights into antiphospholipid antibodies, and more. ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Novel Treatment Targets for Hemophilia A and AML. Have a listen:

MECOM promotes malignant stem cell–like states in aggressive AMLs by directly repressing prodifferentiation gene regulatory programs. Read the plenary paper in Blood: buff.ly/MUfiZMN #BloodJournal #PlenaryPaper #AML

PM PET showed prognostic impact in daratumumab-treated patients. Better PFS was shown for patients who were both PET- and MFC-negative. Read in Blood: buff.ly/84vltb5

Our 67th Annual Meeting may be over, but the abstracts live on. Explore the more than 8,200 #ASH25 abstracts here: www.hematology.org/meetings/ann...

The 2025 Blood Cover Art Contest is live! In recognition of the authors who published their research this year, and the images used for the advancement of hematology, we are asking art enthusiasts to vote for their favorite 2025 blood cover here: pr.easypromosapp.com/p/997812

Patients with ECD-C had more CV morbidities, even before diagnosis, than those without and a matched cohort. Read in Blood Advances: buff.ly/M3r9Egv

'Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia' read in Blood Advances: buff.ly/SX0754O

Patient HIV status associates with tumor mutational burden, and tumor EBV status is associated with transcriptional and cell type changes. Read in Blood Global Hematology: buff.ly/zwPxemu

Last minute holiday gift for the hematologist in your life? The ASH-SAP 9th edition, with practice test questions, case studies, and more, is 10% off right now! Get the best resource for Boards or CME credits. Buy here: https://ow.ly/WyPn50XMA9N? Blood Journals Portfolio

New issue of Blood out now featuring: Molecular modeling of Waldenström macroglobulinemia, Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria, and more. #Blood #BloodJournal #NewIssue #Hemesky ashpublications.org/blood/issue/...

Terrific to have our paper, led by @tjflemin.bsky.social, featured as a plenary article in @bloodjournal.bsky.social today: ashpublications.org/blood/articl...

🎙️ Just published a new episode of Blood Podcast: Novel Differentiation Therapies for AML and Prognostic Value of PET in MM. Have a listen:

How often do you get a second chance? 5 of our Blood journals are offering rapid initial decisions for research manuscripts previously submitted to other reputable journals. Submit today and receive the initial decision in just 3 business days: ashpublications.org/journals/pag...

CD8+ T-cell activation, function, and metabolic reprogramming are suppressed by hypoxia, linked to decreased mTOR activity. Read in Blood Advances: buff.ly/ttZb0at #BloodAdvances #MultipleMyeloma

'Hodgkin lymphoma treatment patterns and outcome disparities in low- and middle-income countries'. Read the full article in Blood Global Hematology: buff.ly/GiSDquA

Curious about what happens after a manuscript is submitted? Our Editorial Fellowship gives you behind-the-scenes access to peer review, manuscript handling, and publishing workflows alongside a dedicated Blood Journal Portfolio editor. Apply today! ow.ly/V65A50XJMvl

New issue of Blood Global Hematology out now featuring: Experience of AL in Latin America, Real-world ibrutinib in CLL, Closing gaps in transplant access, and more. Explore here: ashpublications.org/bloodglobal/...

Targeted lipid nanoparticles deliver fusion transcript-specific siRNA to primary AML cells, achieving fusion gene knockdown. Read in Blood: buff.ly/Eu81RBj

NRF1 orchestrates essential functions in MM by targeting gene promoters linked to ubiquitination and predicts poor outcome prognosis. Read the full article in Blood: buff.ly/hpMM642

Glutamine deprivation in the tumor microenvironment might limit CAR T-cell therapeutic efficacy in patients with cancer. Read the full article in Blood: buff.ly/vuFr7q4

Gut hepcidin decreases iron absorption by downregulating DMT1. A food-grade Lactococcus lactis strain that produces hepcidin prevents iron overload in a mouse model of hemochromatosis. Read the Plenary Paper in Blood: ashpublications.org/blood/articl... #Blood #PlenaryPaper #Hemesky

New issue of Blood out now featuring: Luminal hepcidin targets intestinal DMT1, Improving MM outcomes with bispecific antibody combinations, Neutrophils fine-tune the NET effects of activation, and more. ashpublications.org/blood/issue/... #Blood #BloodJournal

🎙️ Just published a new episode of Blood Podcast: Review Series on Platelet Heterogeneity. Have a listen:

Humanized HbSC mouse model serves as a tool for studying the disease's unique pathophysiology and advancing the development of treatments. Read in Blood Advances: buff.ly/wel6FB0

Drs. Michael Keller and Navid Djassemi examine advancements in virus-specific T cell manufacturing that broaden their accessibility to a wider range of viral infections and immunocompromised populations. 👉 Read their review in @bloodjournals.hematology.org bit.ly/4oJ1Qnd

New issue of Blood Advances out now featuring A tale of 2 mice, Reporting infections in cellular therapies, Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations, and more. ashpublications.org/bloodadvance... #BloodAdvances

Last night's Women in Hematology networking event. We discussed our 2025 Maternal Health Compendium and much more! Explore the collection here: ashpublications.org/collection/4... #maternalhealth #ASH25

Poster walk on Leukemia in Latin America at the Blood Journals Studio hosted by Blood Global Hematology. #ASH25

Stop by our booth today by 2 PM for your free copies of Blood and Blood Advances plus ASH Pubs swag! #ASH25

Congratulations to Dr. Jorge Di Paola for winning the 2025 ASH Mentor Award and Dr. Diane Krause for winning the ASH Advancing Inclusive Excellence Award! @ash.hematology.org President Dr. Avalos was honored to present these at #ASH25

New studies at #ASH25 highlight a shift toward targeted therapies and immunotherapies for blood cancers, showing strong responses with less toxicity compared with traditional chemotherapy. Read for more: https://ow.ly/KR0z50XF6zS#ASH25 #Hematology #HemeOnc

Today's poster walk for Blood RCI, hosted by editors Dr. Gallagher and Dr. Silvestri. They're showcasing cutting-edge therapeutic strategies, from small-molecule activators and mRNA delivery platforms to gene-editing technologies and next-generation hemoglobin-modulating agents. #ASH25

Blood Advances session on How to Peer Review a Scientific Paper. Our Deputy Editor from BA is demystifying the peer review process, covering why it matters, what makes it effective, and how you can contribute meaningfully as a reviewer. #ASH25

We're back at the Blood Journals Studio for our Meet the Editors session hosted by Blood Neoplasia! 🩸 Thank you to EIC Dr. Licht and new Associate Editor Dr. Amengual #ASH25

Poster walk for Blood Neoplasia discussing how Chemotherapy-free options are becoming increasingly available for patients with indolent and aggressive B-NHL. Trials are investigating their safety & efficacy finally challenging the paradigm that chemotherapy is here to stay #ASH25

#ASH25 Poster Walk on Inherited Bleeding Disorders Hosted by Blood VTH. We're having discussions on understanding novel diagnostic tools, personalized treatment approaches, and strategies to overcome barriers in care for conditions like hemophilia and von Willebrand disease.

This morning we also enjoyed a Meet the Editors session at #ASH25 for Blood ICT. Thank you, EIC Dr. Willem Fibbe and Deputy Editor Dr. Caron Jacobson.

We're at #ASH25 Meet the Editors session for Blood VTH! Thank you to EIC Dr. Keith McRae and Deputy Editor Dr. Karin Hoffmeister.

🎙️ Just published a new episode of Blood Podcast: Special Episode: Maternal Health in Hematology. Have a listen:

We've had so much fun with our trainees today at Ash-a-Palooza! As things wind down for the day, make sure you visit the Blood Journals and ASH Image Bank tables if you haven't yet to win fun prizes like buttons and greeting cards and enter extra raffles. #ASH25

All of the amazing editors from across our Blood Journals Portfolio. So lovely having everyone together here at #ASH25!

Ash-a-Paloozais today! Shuttles to SeaWorld run every 15 minutes from the Orange County Convention Center Westwood entrance beginning at 8:00 AM. Follow the corridors on level 3 above Hall C to reach the shuttle pick up. Service runs through 7:30 PM. #ASH25 #ASHTrainee

Welcome to #ASH25! We have a Special Annual Meeting Edition of Blood Advances. Be sure to pick up your free copy this weekend at the ASH Booth (1101) or throughout the convention center. #BloodAdvances #AnnualMeeting #Hemesky

New issue of #Blood out now featuring A structural spotlight on extrinsic Xase complex, Clinical revival of romidepsin with nanoparticles, The secret to staying young: platelet factor 4 and more. ashpublications.org/blood/issue/... #BloodJournal #Hemesky

🎙️ Just published a new episode of Blood Podcast: Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging. Have a listen:

In patients with MF, tagraxofusp monotherapy was well tolerated with a manageable and predictable safety profile. Read the full article in Blood Neoplasia: buff.ly/5zjPoFX

Eight proteomic subtypes with distinct clinical and molecular properties were established, enriching the current classification of AML. Read the full article in Blood: buff.ly/0gbxflz

True functional high-risk MM is very uncommon when comprehensive clinical and molecular profiling is applied. Read in Blood: buff.ly/Fh49MFB

Seeking experience at a medical journal? Our Editorial Fellowship gives early-career clinicians hands-on exposure to the publishing process from peer review to publication. It’s 9 months, remote, and provides invaluable mentorship. Applications now open! ashpublications.org/editorialfellowship